Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Researchers Suggest Neurodegenerative Diseases May Spread through Nanotubes

By LabMedica International staff writers
Posted on 08 Sep 2016
A team of French neurological disease researchers has uncovered a mechanism that may explain how neurodegenerative diseases like Parkinson's disease spread inside the brain.

Investigators at Institut Pasteur (Paris, France) described the movement of alpha-synuclein aggregates from damaged neurons to undamaged neurons through novel structures called tunneling nanotubes (TNTs) that connect cells within the brain.

Classically considered an unstructured soluble protein, wild-type alpha-synuclein forms a stably folded tetramer that resists aggregation. More...
Nevertheless, alpha-synuclein aggregates to form insoluble fibrils in pathological conditions characterized by Lewy bodies, such as Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. These disorders are known as synucleinopathies.

The investigators reported in the August 22, 2016, online edition of The EMBO Journal that using quantitative fluorescence microscopy with co-cultured neurons, they had found that alpha-synuclein fibrils efficiently transferred from donor to acceptor cells through TNTs inside lysosomal vesicles. Following transfer through TNTs, alpha-synuclein fibrils were able to seed soluble alpha-synuclein aggregation in the cytosol of acceptor cells.

The investigators proposed that donor cells with lysosomes overloaded with alpha-synuclein aggregates disposed of this material by hijacking TNT-mediated intercellular trafficking. These findings revealed a possible novel role of TNTs and lysosomes in the progression of synucleinopathies.

Related Links:
Institut Pasteur


New
Gold Member
Hematology Analyzer
Medonic M32B
Portable Electronic Pipette
Mini 96
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.